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Evolutionary growth of knowledge and new 
technological directions of non-thermal 
plasma technology in medicine 
 
ABSTRACT:  The paper analyzes the evolution of scientific production and patenting, main proxies of 
scientific and technological breakthroughs, concerning non-thermal plasma for biomedical applications in 
order to detect emerging technological trajectories. New scientific directions of non-thermal plasma in 
medicine play a critical role because they might generate important innovations that could change the 
clinical practice. Occurrences of scientific products and patents are retrieved with Boolean queries on 
SciVerse database after a meticulous procedure to delineate the most promising applications in 
biomedical sciences. Data are analyzed with two methodological approaches: an exponential model of 
growth and regression analysis. Results show high rates of scientific growth for applications of non-
thermal plasma in disinfection, anticancer treatments, dermatology, whereas for surgery, although values 
of occurrences are similar to the other research fields, it shows a different trend that after the 2005 is 
decreasing due to the peculiar application to materials for implantation. Some arguments are discussed at 
the end of the paper. 
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1. INTRODUCTION 
lasma is a peculiar state of the matter, 
similar to gas, in which a certain 
fraction of the particles are ionized. 
According to Friedman (2008, p.1) a: “ionized 
gas is usually called plasma when it is 
electrically neutral [...] and contains a 
significant number of electrically charged 
particles, sufficient to affect its electrical 
properties and behaviour”. Technological 
applications of plasma physics and chemistry 
are many: TV, mobile phones, synthetic 
fibres, ozone-plasma technology for potable 
water, gas lasers, air-cleaning systems, 
hydrogen production, fuel-cell technology, 
etc. 
The applications depend also on current 
technologies that have allowed the production 
of plasmas at low temperature and at low 
pressure (Tendero et al. 2006). Low-pressure 
and low-temperature (cold) plasmas are able 
to interact with the matter without damaging 
its surface as high-temperature plasmas might 
do. Thus their characters of high reactivity 
and pervasivity (given their gaseous nature) 
can be used profitably for several 
applications, such as surface modification of 
materials like polymers and oxides, or more 
complex applications like those of green 
chemistry (Denes and Manolache 2004; 
Mollah et al. 2000). Plasma technologies have 
vast applications in biology and medicine, 
such as in surgery, sterilization of devices, 
destruction of pathogens, engineering of 
biomaterials, chemoprevention, etc (Fridman 
et al., 2008; Weltmann et al., 2010). “Plasma 
medicine as an independent medical field is 
emerging worldwide in a way comparable to 
the development of laser technology years 
ago” (Ferreira et al., 2012). Plasma medicine 
can be applied for surface modification (e.g. 
in biomaterials), bio-decontamination and for 
therapeutic applications (in this case only 
atmospheric-pressure plasmas can be used). In 
fact, living matter is not damaged by its 
interaction, and thus its characteristics can be 
exploited for therapeutic uses without main 
side effects for patients and with better results 
(i.e. effective treatments) than older 
technologies. 
The purpose of this paper is to analyze the 
evolutionary growth of non-thermal plasma in 
order to detect fruitful and emerging 
applications in medicine. In particular, the aim 
of this analysis is to pinpoint emerging 
technological trajectories that present the 
highest growth in terms of scientific 
knowledge. 
The present work is organized as follows. 
The next section contains a theoretical 
framework introducing and discussing plasma 
applications that are analyzed in the 
experimental work. In the third section 
research methodology is presented, while the 
fourth section contains the main results. In the 
fifth and last section, results are discussed and 
conclusions are drawn. 
2. THEORETICAL BACKGROUND: 
PLASMA TECHNOLOGY 
It must first be noted that the word “Plasma” 
is not unambiguous, as it indicates not only 
the above described state of the matter but 
also the liquid component of blood1. The 
present study focuses on plasma as a neutral 
ionised gas, made by particles – free radicals 
and excited or non-excited molecules, positive 
                                                     
1 Due care has been taken during database building 
procedure to overcome this homonymy. 
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and negative ions, electrons, atoms, photons – 
in permanent interaction (Moreau et al., 2008, 
p. 611). Plasmas exist in nature in several 
contexts (like in polar aurorae) and can be 
obtained artificially via different methods, 
such as thermal or non-thermal. 
Thermal plasmas are obtained at high 
pressure and with the use of electrical currents 
of a substantial power (up to 50 MW): 
“Thermal plasma processes have a long 
history of industrialization, of which a notable 
application is coating metallic substrates with 
hydroxyapatite (HA) for orthopaedic 
implantation. Despite its industrial efficiency, 
thermal plasma deposition results in 
undesirable changes to thermally sensitive 
substrates such as HA” (Tan et al., 2012). 
Non-thermal plasmas are obtained at lower 
pressures and use less power. Recently, a new 
technology can represent a third category: 
non-thermal atmospheric plasma, so-called 
cold plasma. This plasma is intermediate 
between the two others and in general is 
included in the set of the non-thermal plasmas 
because is formed near atmospheric pressure 
and ambient temperature: “The temperature of 
non-thermal atmospheric plasma […] is low, 
at around room temperature” (Kim et al., 
2010, p. 530). 
Low-temperature non-equilibrium plasmas 
play an increasing role in biomedical 
applications, though user-friendly sources 
need to be developed. For instance, 
microwave generated atmospheric-pressure 
plasmas enable lower facility and process 
costs in a variety of plasma processing and 
manufacturing techniques (Ferreira et al., 
2012, passim). 
In particular, medical applications of non-
thermal plasmas are of two main typologies: 
“direct and indirect plasma treatment, 
differentiated by the amount of charged 
species applied to the surface of the living 
tissue” (Tan et al., 2012).  
• Direct treatment generates a non-thermal, 
atmospheric-pressure plasma in direct 
contact with the living tissue, which is used 
as one of the discharge electrodes. The 
living tissue, in “direct plasma treatment”, is 
in direct contact with the plasma and this 
technique can be mainly applied in skin 
sterilization, blood coagulation, in assisting 
wound healing and tissue regeneration.  
• On the other hand, indirect plasma treatment 
is represented by atmospheric pressure 
plasma jets. This approach creates the 
plasma remotely and delivers its afterglow 
by a jet to the desired location; the sample is 
placed at some distance from the plasma and 
only exposed to the formed reactive species 
(cf. Fridman et al., 2007; Laroussi, 2009; 
Shashurin et al., 2008). 
In order to introduce the topics that are 
analyzed and discussed in this study the 
following paragraphs present a selection of 
some key biomedical applications of cold 
plasmas in scientific literature and patenting 
activity. 
2.1 Applications in the cure of cancers 
Non-thermal atmospheric-pressure plasmas 
can be applied in medicine to induce growth 
arrest in tumour cells and could have vast 
applications in immunology or cancer 
therapies. In fact, the main role of indirect 
plasma treatment on cell apoptosis and 
necrosis has been discovered recently. Haertel 
et al. (2011) argue that: “Plasma is also able to 
induce apoptosis, which is an important 
feature when treating cancer cells” (cf. also 
Kim et al. 2010). 
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Keidar et al. (2011) study the effect of cold 
plasma on several lines of cancer cells both 
in-vitro and in-vivo. The study: “shows […] 
new response of cancer cells upon treatment 
with cold plasma jets” (p. 1300). Results 
display that some cancer cells could be 
selectively ablated by plasma jets leaving 
unaffected their corresponding normal cells. 
Involved mechanisms could be plasma-
induced apoptosis and decrease of velocity of 
cell migration. 
Hofmann et al. (2010) report the use of 
Cold Plasma Coagulation (CPC) in the 
treatment of patients presenting malignant 
pleural mesothelioma, a cancer provoked by 
the exposition to asbestos, for which no real 
cure exists so far. CPC was used in 
combination with chemotherapics perfusion in 
order to avoid pleural effusion and cardiotoxic 
effects and to sterilize the site, thus achieving 
better quality of life for patients. 
Vandamme et al. (2012) perform in-vivo 
tests evaluating the effect of non-thermal 
plasmas on cancer cell lines. According to 
their results plasma generates reactive oxygen 
species that interact with DNA of cancer cells, 
inducing cell apoptosis. The analysis of how 
non-thermal atmospheric pressure plasma 
influences mononuclear cells is also important 
to understand interactions into plasma–
immune cells (Haertel et al., 2011a). 
However, the molecular mechanisms in 
plasma-induced cell growth arrest are not well 
understood. Kim et al. (2010, p. 530) analyze 
the feasibility of non-thermal atmospheric 
plasma treatment for cancer therapy and 
examine the mechanism by which plasma 
induces anti-proliferative properties and cell 
death in human colorectal cancer cells. Non-
thermal atmospheric plasma is less invasive 
and more selective to cancer cells as a 
targeted means of treatment for cancer 
patients. In particular, the technology is an apt 
anticancer treatment for established or pre-
neoplastic defects of the: “esophagus, bladder 
and bowel, which are anatomically difficult 
areas for traditional surgical and radiotherapy 
approaches” (Kim et al., 2010, p. 537). 
However, these innovative techniques may 
have some limitations and generate fruitful 
effects mainly in superficial premalignant 
defects and early superficial cancer for 
disinfecting and removing microscopic 
residual cancer (Kim et al., 2010, p. 537). 
2.2 Applications in the suppression  
of pathogens and as disinfectant 
Advances in non-thermal atmospheric 
plasma have also led to applications in 
treatments to suppress pathogens and 
infections (Stoffels et al., 2006) or sterilize 
tissues (Shashurin et al., 2008; Moisan et al., 
2001; 2002). Involved mechanisms are: “In 
the case of medium and low-pressure 
discharges, the inactivation mechanisms are 
the DNA destruction by UV irradiation and 
the erosion of the micro-organism through 
intrinsic photodesorption and etching 
(eventually enhanced by UV radiation)” 
(Moisan, 2001, p. 18). Two or three distinct 
phases characterize plasma inactivation of 
bacteria and spores (Moisan, 2002, p. 357). 
Bactericidal effects of cold plasmas on two 
different types of bacteria have been 
investigated by Morris et al. (2009). Results 
show that exposing bacteria to cold plasma, it 
kills vegetative cells of both bacteria, while 
spores are killed only for one of the two. 
Instead, Xu et al. (2011) study effectiveness 
of atmospheric-pressure non-thermal plasma 
towards bacteria embedded in biofilms, such  
as the Neisseria gonorrhoeae; in this case, 
biofilms bacteria are particularly difficult to 
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remove, but plasma seems effective towards 
destruction of such bacteria. Mechanisms of 
bacteria inactivation are also studied by Joshi 
et al. (2011). According to their observations: 
“Plasma treatment causes morphological 
changes in E. coli that are peculiar to 
oxidative stress and eventual death” (p. 1055) 
and “Plasma-induced oxidants attack the cell 
membrane and depolarize it in E. coli” (p. 
1058). Instead, Brun et al. (2012) investigate 
the use of Plasma for the disinfection of 
ocular cells and tissues: results show effective 
action towards both bacteria and fungi. 
In addition, Burts et al. (2009) show the use 
of atmospheric non-thermal plasma as a 
disinfectant for objects contaminated with 
methicillin-resistant Staphylococcus aureus. 
Hence, generation of plasma is a promising 
method for disinfection of objects or surfaces 
that warrants further study in hospital settings. 
Terrier et al. (2009) study the efficiency of 
cold oxygen plasmas as disinfectant for 
airborne viruses with particular regard to 
influenza viruses in nebulized sospensions. 
Results show positive effects: “gas plasma 
[…] is responsible for an important decrease 
of the viral titer for all the three respiratory 
viruses” (p. 122). This effect is mainly 
attributed to the presence of Ozone in the 
plasma. 
2.3 Applications in surgery: surface 
modifications of materials for 
transplantation and orthopaedics 
The use of plasmas in surgery is strongly 
connected to surface modifications of 
materials for transplantation of various body 
parts, and particularly in orthopaedics (often 
performed with the use of hot plasmas). For 
instance, Chen et al. (2009) study antibacterial  
 
effect of silver-containing titanium coatings 
for bone-substitution Titanium-based 
prostheses, prepared via a plasma spray 
technique. Results display antibacterial 
activity mainly due to the presence of 
nanostructured silver. Jamieson et al. (2011) 
study, instead, mechanical properties of 
spongy coatings of prostheses realized with 
Plasma spraying. 
Schrader et al. (2012) study the effects on 
osteointegration of Titanium prostheses where 
a bioactive nanometric surface ceramic 
coating, realized with Plasma chemical 
oxidation, is enriched with bioactive elements 
(Calcium and Phosphorus) and tested on rats. 
The surface supports osteointegration and 
implant fixation. A similar device has been 
tested by Ripamonti et al. (2012). 
Surmenev (2012) performs a review of 
plasma-assisted methods for the fabrication of 
coatings based on Calcium Phospates. Several 
Plasma methods are described (e.g. Radio-
frequency magnetron sputtering, Plasma 
spraying, Pulsed lased deposition, Ion beam-
assisted deposition) as well as the 
characteristics of obtained coatings. Positive 
results of the techniques are also shown. 
Finally, Tan et al. (2012) analyze plasma 
generated by applying energy to a gas 
resulting in a mixture of ions, electrons and 
neutral species.  
They investigate the influence on osteogenic 
lineage cells or bone tissue and applications in 
surgical repair of hard tissue. This study 
shows that atmospheric pressure plasma is a 
potent tool for modifying the biological 
function of a material without causing thermal 
damage, such that adhesion molecules and 
drugs might be deposited on the original 
coating to improve performance. 
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2.4 Applications in dermatology 
Silk fibroin fibres can be surface-modified 
with the use of Plasmas in order to be used for 
skin regeneration treatment: surface 
modifications depend on the gas used for 
Plasma generation (Jeong et al., 2009). In 
fact, another important medical field of 
application of Cold Plasmas is dermatology 
and wound healing. Lademann et al. (2011) 
report the use of Plasmas for drug delivery 
through the skin barrier in an in-vitro 
experiment. No thermal damage was observed 
and “the treatment of the skin surface with 
tissue-tolerable plasma is an efficient method 
for stimulating the penetration of topically 
applied substances through the skin barrier 
with a low risk of infection” (p. 490). 
Isbary et al. (2011) show the use of Cold 
Atmospheric Argon Plasma as a treatment to 
cure rare Hailey-Hailey Disease, caused by 
gene mutation and that nowadays is still 
difficult to cure. This was done to treat the 
infection provoked by the disease and to test 
the effects on the disease of reactive oxygen 
species. Effectiveness of the therapy shows 
that it offers a novel treatment option for 
affected patients. 
Procedures for control of wound bleeding 
and wound healing with the use of Plasmas 
are reported by Nastuta et al. (2011) and by 
Kuo et al. (2012). Their experiments, 
performed in-vivo on animals, show positive 
effects, with shorter healing time after Plasma 
application. 
This background is important to analyze the 
technological trajectories of non-thermal 
plasma in medicine. Next section presents the 
methodology of research.  
3. RESEARCH METHOD 
The main interest of this paper is to pinpoint 
current research fields of non-thermal plasma 
that support technological trajectories of 
groundbreaking applications in medicine. Of 
course, this is a complex issue affected by 
several factors. Thus this work proposes a 
straightforward approach that tries to detect 
emerging scientific fields and associated 
technological trajectories of non-thermal 
plasma in medicine. Nelson (2008, p. 489) 
considers: “that a strong body of scientific 
understanding enables technological progress 
to be rapid and sustained […] the research in 
the engineering disciplines and applications 
oriented sciences aims to develop 
understanding of what is going on in the 
operation of the relevant field of practice, so 
as to illuminate how to advance it”. Moreover, 
Grupp (2000, p. 143) argues that: “innovation 
literature centres more on technical advance 
and less on scientific change”. 
As a matter of fact, it is important to 
ascertain that scientific advances and changes 
can be considered as ice-breakers for new 
scientific research fields, creating new 
pathways for future patterns of technological 
innovation. In order to investigate the 
directions and intensity of scientific research 
in those research fields that may drive future 
technological pathways, we use a 
methodology based on the analysis of 
numbers of scientific outputs (mainly journal 
articles, but also conference papers, book 
chapters etc.) and patents. Data have been 
retrieved with the use of the database 
SciVerse® (2012) by Elsevier carrying out a 
search of critical keywords. 
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SciVerse® has been preferred for the 
present study as it encompasses both scientific 
products and patents (together with web 
documents); it is in fact a meta-database, 
retrieving data from other databases (for 
instance Scopus® and Pubmed®) for 
scientific production, and from World 
Intellectual Property Organization, European 
Patent Office, United States Patent and 
Trademark Office, Japan Patent Office and 
other European and non-European patent 
offices for patent applications. Database has 
been built retrieving occurrences according to 
Boolean sets of keywords and carefully 
counting the number of scientific 
products/patents per each year in order to 
avoid the spurious count of duplicates. Data 
have been retrieved on June 2012 exploiting 
the search-and-retrieve system of SciVerse®, 
inserting in the search window composite 
queries and using the “title-abs-key” code, 
thus enabling search only in Title, Abstract or 
Keywords of scientific products. Data were 
collected up to 2011 and go back up to 1974. 
Queries are reported in Appendix 1 in Table 
1A. The analysis has been performed on data 
from 1990 onwards only, when the quantity of 
scientific/technological products starts to be 
more consistent. As a general rule data mining 
has been performed including (when needed) 
keywords into quotation marks (i.e. “search 
for the exact phrase”). 
Search queries have been realized 
combining (with the Boolean operator 
“AND”) for each query two groups of 
keywords and Boolean operators.  
The first group of keywords is common to 
all queries. It is relative to plasma and it 
contains all its most relevant definitions. This 
group of keywords has been realized with due 
care avoiding to incorporate citations of 
scientific products and patents on “blood 
plasma”. Several tests have been performed 
before getting  to the final queries. 
The second group of keywords is specific 
for each query, and encompasses all the terms 
that are relevant for the specific subject, 
obtained via study of scientific literature and 
checked via several preliminary queries on 
Scopus® (2012), which also support relevant 
keywords on different topics. 
After performing the queries, results have 
been checked to control duplicates and 
spurious data. Table 1 in Appendix 1 contains 
all keywords sets used for our database. 
Data mining has been performed in June 
2012, and is focused on the time horizon  
1990 – 2011 for scientific research products 
(articles, books and related works) and 
patents. The analysis also considers the 
citations of papers to better evaluate the 
evolutionary growth of research fields. 
As an acceleration of scientific activity in 
some research fields is a first main signal of 
scientific accumulation and continuous 
advances, it is critical to measure and analyse 
the rates of scientific and technological 
growth that indicate the evolutionary growth 
of technological trajectories in the medium-
long term. The rate of scientific advances is 
measured by the number of scientific 
products, whereas technological advances are 
measured by the number of patents. An 
exponential model is a fruitful approach to 
measure the patterns of critical scientific 
fields based on the following assumptions 
(Coccia 2012): 
1: 0P is the number of scientific articles 
       at t=initial (e.g. 1996) 
2: tP is the number of scientific articles 
        at 2011 
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3: t is the period analyzed 
4: scientific articles are a proxy of the 
        scientific knowledge under way 
The model is: 
rt
t ePP 0  where e is the base of natural 
logarithm (2.71828…). 
Hence    trt e
P
P  
0
 ;   tr
P
P
Log t 
0
; 
.
0
t
P
P
Log
r
t






          [1] 
r = rate of scientific (or technological) 
advances 
This method can offer an analytical 
framework for detecting promising scientific 
trends that may support main technological 
trajectories and radical innovations that will 
impact the healthcare. 
In addition, data have also been analyzed by 
an econometric model based on time series to 
better understand new directions and compare 
the results with previous approach (based on 
Eq.[1]). As some distributions are not normal, 
a logarithm transformation has been applied to 
have apt distributions for parametric 
estimates. 
In particular, the functional relationship is: 
Scientific-technological output (articles) of 
non thermal plasma applications in medicine 
 = f (Time) 
The specification is based on a simple 
regression model: 
titi uTimeyLn ,10,   (growth model) [2] 
where: 
the t subscript indicates the time  
ui,t = error term 
This equation [2] is estimated by Ordinary 
Least Squares (OLS), using the statistics 
software SPSS (Statistical Package for the 
Social Sciences). Moreover, results show R 
Square statistic, which is a measure of the 
strength of association between the observed 
and predicted values of the dependent 
variable. The large R Square values indicate 
strong relationships for models. Adjusted R 
Square is a “corrected” measure due to the 
fact that R Square statistic penalizes models 
with large numbers of parameters. The 
ANOVA table tests the acceptability of the 
model from a statistical perspective: ANOVA 
table is a useful test of the model's ability to 
explain any variation in the dependent 
variable. The significance value of the F 
statistic is less than 0.05, which means that the 
variation explained by the model is not due to 
chance. 
Next section presents the main results.  
4. RESULTS 
Statistical analysis is based on two samples 
respectively of 1,081 scientific products and 
of 154 patents. These samples are the basis to 
apply models for the analysis of the scientific 
and technological knowledge growth based on 
scientific outputs; this enables to detect 
promising scientific pathways of such key 
technologies. 
Figure 1 reports graphically the number of 
scientific products per year for the analyzed 
topics. It must be noted that for Surgery 
applications of non-thermal plasma, SciVerse 
data start in 1997. 
Figure 1 shows that the scientific evolution 
in surgery follows a pathway that is rather 
different from that of the other topics. In fact, 
while cancer, disinfection and dermatology 
applications present a more or less continuous 
growth in scientific production from 1990 
onwards, applications of non-thermal plasma 
in surgery have a peak of publications around  
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Figure 1 – Trends of scientific products  of non-thermal plasma per main applications 
 
mid-2000s and then a decrease, though still 
presenting a rather high production at the end 
of the period. 
This fact might be due to the specific topic 
of most part of the literature regarding 
application of plasma for purposes of surgery. 
A closer analysis of the scientific products 
shows that most applications are related to the 
use of plasma for surface modification of 
materials or object to be used in surgery for 
the substitution of body parts (e.g. bone parts) 
or for implantations (such as, nets for surgical 
uses2). This might prove that the technological 
trajectory of such applications of non-thermal 
plasma is following a different pathway, more 
linked to the trajectory of the materials 
development rather than to the specific 
trajectories presented by other non-thermal 
                                                     
2 Such nets are used to retain organs in their position 
after heavy surgical operations. 
plasma medical applications. Table 1 reports 
the evolutionary rates of growth of scientific 
products for the main explored topics: non-
thermal plasma for the cure of cancer, for 
bacterial disinfection, for surgical applications 
and for dermatology applications. Such topics 
have been chosen in literature as the most 
promising in the field (as theoretical 
framework shows) and those presenting the 
widest scientific production in the last years. 
Such rates of growth are a strong indicator 
highlighting the emerging directions of these 
research fields and technological trajectories 
that may support vital applications in 
medicine. Data of patents are low and we 
cannot calculate the rate of scientific growth. 
The last column has only the sum of patents 
over time. 
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Table 1. Rates of scientific growth of scientific fields in non thermal plasma in medicine 
(Data based on scientific articles and patents by SciVerse, 2012) 
TOPIC 1st year Sum of Articles Years Pt/P0 
r (Eq. [1]) 
% Sum of patents 
Cancer 1981-2011 91 22 20 13.617 5 
Disinfection 1979-2011 457 24 67 17.519 104 
Surgery 1998-2011 427 15 0.655 2.819 35 
Dermatology/ 
skin regeneration 1974-2011 106 25 17 11.333 10 
 
 
Non-thermal plasma applications for 
disinfection present the highest growth rate 
(more than 17 %), followed by applications 
for the cure of cancer (almost 13 % growth) 
and by dermatological applications (more than 
11 %). All three research trajectories show a 
growing rate of scientific production and thus 
might drive innovations and research in 
medicine in the not-too-distant future. 
Conversely applications in surgery show a 
negative trend (almost -3 %). Scientific 
production has also been studied from the 
point of view of spatial dimension considering 
the best performing countries. Table 2 
presents the 10 top countries per number of 
scientific products. Results show that the US 
are leader in all research fields of the 
application of non-thermal plasma, followed 
by Germany. Other countries are behind those 
two main geo-economic subjects, with 
different positions and production according 
to the specific research field. 
 
Table 2: Top 10 countries per number of scientific products (presenting at least one 
affiliation) concerning non-thermal plasma applied to biomedical fields  
Cancer 1
st year 
1985 Disinfection 
1st year 
1979 Surgery 
1st year 
1974 
Dermatology 
/skin 
regeneration 
1st year 
1974 
United States 44 United States 141 United States 160 United States 51 
Germany 16 Germany 86 Germany 48 Germany 28 
South Korea 15 China 79 The Netherlands 47 Switzerland 11 
China 13 South Korea 42 China 45 The Netherlands 9 
United 
Kingdom 10 Japan 36 Japan 41 South Korea 6 
France 8 France 35 Italy 36 Romania 5 
Japan 4 Romania 23 Switzerland 30 Denmark 4 
Romania 4 United Kingdom 20 France 28 Japan 4 
Australia, 
Canada, Italy, 
The 
Netherlands, 
Spain 
3 
The Netherlands 17 United Kingdom 25 Brazil, China, 
Italy, Sweden, 
Taiwan 
3 Russian 
Federation 13 Taiwan 17 
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Table 3: Citations concerning non-thermal plasma applied to biomedical fields 
 Cancer Disinfection Surgery Dermatology/ skin regeneration 
Total received citations 1726 6583 9802 2648 
Scientific products 1996-2012 126 530 516 118 
Average received citations per 
product 13.70 12.42 19.00 22.44 
Average received citations per 
year 101.53 387.24 576.59 155.76 
 
In order to evaluate the quality of the 
production in the different research fields the 
number of citations concerning scientific 
products has been retrieved on Scopus (as 
SciVerse does not present citations data). As 
Scopus counts citations from 1996 onwards, 
only scientific products from 1996 to 2012 
have been considered.  
Table 3 presents the data on total citations 
and scientific products, as well as the average 
number of citations per product and per year. 
Figure 2 presents instead the trends of 
received citations. Surgery applications of 
non-thermal plasma have the maximum 
number of average received citations per year. 
Nevertheless this research field around year  
 
2008 stabilizes and does not grow anymore. 
“Disinfection” instead, though being less high 
in the total number of papers and citations, 
grows quickly from 2006 onwards. If we 
consider jointly these data with those in figure 
1, we easily can see that “Surgery” peaks the 
number of scientific products around 2004, 
while “Disinfection” has an acceleration such 
that the trend surpasses the surgery, which in 
the last time span presents a rather stable 
growth. Thus this research field 
“Disinfection” seems to be the most 
promising application of non-thermal plasma 
in biomedicine, associated to surgery, 
considering the profile of scientific production 
and citations. 
 
 
 
Figure 2: Trends of citations concerning non thermal plasma applied 
 for specific biomedical fields
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Table 4 - Descriptive Statistics (patents) 
 Cancer Disinfection Surgery Dermatology 
Mean 1.250 6.117 2.062 2.500 
Std. Error of Mean 0.250 0.954 0.432 0.957 
Std. Deviation 0.500 3.935 1.730 1.915 
Skewness 2.000 0.061 1.213 0.855 
Std. Error of Skewness 1.014 0.550 0.564 1.014 
Kurtosis 4.000 -1.197 0.413 -1.289 
Std. Error of Kurtosis 2.619 1.063 1.091 2.619 
 
 
 
Table 4 contains descriptive statistics for 
patents, whereas table 5 contain those for 
articles. Patents shows that the higher 
arithmetic mean over time is relative to the 
applications of non thermal plasma for 
disinfection (6.1 patents), followed by 
dermatology (2.5) and applications in surgery 
(2.06 patents). Applications for the cure of 
cancer present a much lower result (1.25). 
As far as scientific products are concerned 
(table 5), higher arithmetic mean of scientific 
output is that of plasma application in 
disinfection (more than 14 articles per year), 
surgery (more than 13 articles), whereas 
applications in dermatology and cure of 
cancer have much lower values. Nevertheless, 
standard deviation is also higher (high 
dispersion of values). In addition, some 
distributions are not normal; in this case the 
logarithmic transformation is an apt approach 
to have normal distributions and apply 
parametric estimates for analyzing by 
econometric models these time series  
(table 6). 
 
 
 
Table 5 - Descriptive Statistics (articles) 
 Cancer Disinfection Surgery Dermatology 
Mean 2.676 14.281 13.774 3.419 
Std. Deviation 5.226 21.007 16.225 4.372 
Skewness 2.751 1.505 0.779 2.152 
Std. Error of Skewness 0.403 0.414 0.421 0.421 
Kurtosis 6.643 1.023 -0.473 4.333 
Std. Error of Kurtosis 0.788 0.809 0.821 0.821 
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Table 6 Descriptive Statistics (Logarithmic values of articles) 
 LnCancer LnDisinfecta LnSurgery LnDermatology 
Mean 0.772 2.007 2.241 1.217 
Std. Error of Mean 0.199 0.3156 0.340 0.172 
Std. Deviation 0.976 1.548 1.594 0.806 
Skewness 1.320 0.064 -0.721 0.477 
Std. Error of Skewness 0.472 0.472 0.491 0.491 
Kurtosis 0.884 -1.648 -1.445 -0.001 
Std. Error of Kurtosis 0.918 0.918 0.953 0.953 
 
 
The econometric model of simple regression 
are applied to the scientific output represented 
by articles. The model is not applied to patent 
time series because this technological output 
is low and not suitable for econometric 
estimates. Models are estimated by Ordinary 
Least Squares (OLS) using SPSS statistics 
software. First of all, it must be noted, from 
results reported in table 7, that the 
econometric models explain a high variance in 
the data (see adjusted R square), except for 
model 4 (Dermatology applications). In 
addition, the parametric estimates of these 
models are unbiased, and the significance and 
the overall explanatory power of coefficients 
are excellent. 
 
 
Table 7: Parametric estimates considering scientific outputs (articles) over 1960-2011 
Dep. variable / 
Models Estimated relationship 
Goodness of 
fit ANOVA 
Applications of 
non-thermal plasma 
 
    
1. LnCancer  yt= 202.12***  + 0101 xt*** R
2
 adj
 
=0.60 F=35.34  (sig.0.00) Cancer therapy 
 (34.13) (0.017) S=0.62   
2. LnDisinf  yt= 375.02***  + 0.189 xt*** R
2
 adj
 
=0.84 F=120.52 (sig.0.00) Disinfection 
 (34.34) (0.017) S=0.62   
3. LnSurgery  yt= 358.28***  + 0.180 xt*** R
2
 adj
 
=0.57 F=28.72  (sig.0.00) Surgery treatments 
 (67.28) (0.034) S=1.05   
4. LnDerma yt= 143.83**  + 0.073 xt*** R
2
 adj
 
=0.34 F=11.91 (sig. 0.003) Dermatology Treat. 
Note: The independent variable is time; The dependent variable is the number of scientific publications (over 1970-2011) of non 
thermal plasma applied in medicine. The second column is the estimate of the constant. Underneath it, in parentheses, its standard 
error. The third column is the estimate of . Underneath it, in parentheses, its standard error. The fourth column has adjusted R2 of 
the regression and below it, the standard error of the regression. The fifth column has the results of the Fisher test, to its right the 
significance. In the last column the typology of applications by non thermal plasma. t=time, ***    Parameter is Significant at 0.001; 
** Parameter is Significant at 0.05. 
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In particular, Table 5 shows that the higher 
coefficient of regression is that of non thermal 
plasma applied for disinfection and surgery. 
Data show that scientific outputs concerning 
applications of non thermal plasma in 
medicine for disinfection have an expected 
increase of approximately 19% per year, 18% 
in surgery treatments, and about 10% in 
cancer therapies. Lower increase per year is 
represented by Dermatology, although the 
latter estimated relationship has a low 
explanatory power. 
5. DISCUSSION AND CONCLUDING 
REMARKS 
Current socio-economic change, associated 
to the continuous advances of current 
scientific trajectories, is very active and gives 
strong possibilities to open up new 
opportunities for basic and applied research, 
as well as technological applications. 
Innovation in biomedical field is 
particularly important as it bears the promise 
of better health for large shares of population 
and of better lifestyle. Economic implications, 
due to the high cost of care of diseases, are 
also rather strong in this research field. 
Patterns of technological innovation in 
medicine (such as targeted therapies, 
nanomedicine, etc.) driven by new 
technological paradigms3 have been 
generating a revolution in clinical practice, 
increasing the overall survival of patients, 
                                                     
3  First of all, it is important to state the technological 
paradigms that is “ ‘model’ and ‘pattern’ of solution of 
selected technological problems, based on selected 
principles derived from the natural science and on 
selected material technologies” (Dosi, 1982, p. 152, 
original emphasis). 
quality of life and improving the wellbeing of 
societies (Coccia 2012). 
The present study has analyzed the 
scientific-technological trajectories of the 
clinical applications of non-thermal plasmas 
that are one of the vital scientific fields 
presenting most technological advances, as 
witnessed by the present research. We have 
analyzed main technological trajectories of 
non-thermal plasma and showed the intensive 
evolutionary growth of scientific research and 
technological applications in patenting in 
some emerging research fields. The empirical 
evidence, based on numbers of scientific 
products and patents (chosen as indicators of 
evolutionary growth of science and 
technology), shows the following results: 
- Biomedical applications of non-thermal 
plasma present a high rate of growth both in 
scientific production and in patenting; 
- Rates of growth differ according to 
applications in medicine; 
- Rates of growth of scientific evolution of 
non thermal plasma applied in medicine are 
well described both by a exponential growth 
model and by a regression model based on 
time series, though results slightly differ; 
- Rates of growth, measured by the 
exponential model (Eq.[1]), are higher for 
applications of non-thermal plasma in 
disinfection and anticancer treatments, while 
surgical applications present a negative 
growth rate; 
- Rates of growth, estimated by regression 
analysis (Eq.[2]), are higher for applications 
of non-thermal plasma in disinfection and 
surgery; 
- geometric representation (figure 1) shows 
increasing trends of non-thermal 
applications in medicine, except applications 
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in surgery that show a maximum around in 
2003 and then decrease since 2004 or 
thereabouts. This difference in the evolution 
of scientific-technological production can be 
explained paying a closer look to the content 
of the scientific articles encompassed in the 
query. Most part of them is about 
applications of plasmas for surface 
modification of materials for body 
implantation: thus the technological 
trajectory followed is rather that of the 
materials than that of plasmas for 
biomedicine. 
- Results show that the US are leader in all 
research fields of the application of non-
thermal plasma, followed by Germany. 
- Surgery applications of non-thermal plasma 
have the maximum number of average 
received citations per year. Nevertheless, 
this research field around year 2008 
stabilizes and does not grow anymore. 
- “Surgery” peaks the number of scientific 
products around 2004, while “Disinfection” 
has an acceleration such that the trend 
surpasses the surgery, which in the last time 
span a rather stable growth.  
- In short, “Disinfection” seems to be the most 
promising application of non-thermal 
plasma in biomedicine, associated to 
surgery, considering the profile of scientific 
production and citations. 
The high evolutionary growth of non-
thermal plasma applied in medicine is due to 
its ability to interact in several ways with the 
living matter without damaging it, and to 
modify its surface when needed, and can be 
also a cheaper solution when scale economies 
are applied and overall costs for healthcare are 
considered. This paper shows that non-
thermal plasma is an apt groundbreaking 
technology for disinfection and 
decontamination. This fact is also confirmed 
by other researches applied for food industry 
showing that non-thermal plasma seems to be 
a promising technology for decontamination 
of fresh food from bacteria Staphylococcus 
aureus, Listeria monocytogenes and 
Pseudomonas aeruginosa, respectively 
(Coccia and Finardi, 2012). This 
groundbreaking character is confirmed also by 
the fact that scientific-technological 
innovation clusters (encompassing several 
stakeholders), are being created and supported 
in order to promote innovative activities in the 
field of biomedical use of non-thermal 
plasmas (see Gebhardt, 2012 for the German 
case). 
Nevertheless, it must be noted that such 
promising scientific-technological trajectories 
in medicine, with high rates of growth, have a 
number of occurrences (scientific products 
and patents) lower than other relevant fields 
where non-thermal plasmas are applied, such 
as applications for conservation of fresh foods 
(cf. Coccia and Finardi, 2012). Thus it can be 
said that such applications of non-thermal 
plasma in medicine are strongly promising but 
are also in their infancy, and thus at the 
beginning of their evolutionary patterns of 
technological innovation. But it is also true 
that biomedical applications of new plasma 
technologies are strategic, because of the 
possible improvement of life conditions and 
the economic outcome that they might have in 
term of efficacy treatments and savings from 
expenses in hospitalization. Current evolution 
due to applications of non-thermal plasma can 
become soon a key element in the field of 
biomedicine. 
Although it is difficult to cover and analyse 
all scientific information concerning these 
emerging research fields, we hope that this 
paper can provide the fundamental 
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technological trajectories of non-thermal 
plasma that could improve the clinical 
practice as well as the quality of life and 
wellbeing of future societies. Nevertheless, 
this study deserves further investigations 
based on more comprehensive models and 
data.  
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APPENDIX 1: – LIST OF BOOLEAN SETS OF KEYWORDS AND OF MEDICAL AREAS 
OF INVESTIGATION 
 
Table 1A  
Cure of cancer: 
title-abs-key(("non-thermal plasma*" OR "non thermal plasma*" OR "cold plasma*" OR "plasma 
jet*" OR "atmospheric pressure plasma*" OR "atmospheric pressure cold plasma*" OR 
"atmospheric plasma*" OR "plasma plume*" OR "Plasma spray*" OR "plasma torch*")  AND 
(cancer* OR tumor* OR "tumoral cell*" OR "tumor cell*" OR "tumour cell*" OR neoplas* OR 
"anticancer treatment*" OR "metastasis" OR "*carcinoma" OR "melanoma")) 
Disinfection of objects from pathogens: 
title-abs-key(("non-thermal plasma*" OR "non thermal plasma*" OR "cold plasma*" OR "plasma 
jet*" OR "atmospheric pressure plasma*" OR "atmospheric pressure cold plasma*" OR 
"atmospheric plasma*" OR "plasma plume*" OR "Plasma spray*" OR "plasma torch*") AND 
(sterilization OR sterilisation OR germici* OR bacterici* OR "bacteria removal" OR "bacterial 
infection" OR decontamination OR biodecontamination OR bio-decontamination OR "anti-
bacterial agents" OR "antiinfective agent" OR listeria OR "staphylococcus aureus" OR 
salmonella OR "escherichia coli" OR "pseudomonas aeruginosa")) 
Surgery: 
title-abs-key(("non-thermal plasma*" OR "non thermal plasma*" OR "cold plasma*" OR "plasma 
jet*" OR "atmospheric pressure plasma*" OR "atmospheric pressure cold plasma*" OR 
"atmospheric plasma*" OR "plasma plume*" OR "Plasma spray*" OR "plasma torch*") AND 
(surgery OR surgical OR laparoscop* OR laparotomy)) 
Dermatology and skin regeneration: 
title-abs-key(("non-thermal plasma*" OR "non thermal plasma*" OR "cold plasma*" OR "plasma 
jet*" OR "atmospheric pressure plasma*" OR "atmospheric pressure cold plasma*" OR 
"atmospheric plasma*" OR "plasma plume*" OR "Plasma spray*" OR "plasma torch*") AND 
("skin disease*" OR "skin sterilization*" OR "wound* healing" OR "skin burn*" OR "skin 
ulcer*" OR "wound* patholog*" OR "cutane* patholog*" OR "skin Neoplasm*" OR psoriasis 
OR erythema OR "skin infection*" OR epidermis OR dermatitis OR "wound infection")) 
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